Загрузка...
Strategy to targeting the immune resistance and novel therapy in colorectal cancer
Assessing the CRC subtypes that can predict the outcome of colorectal cancer (CRC) in patients with immunogenicity seems to be a promising strategy to develop new drugs that target the antitumoral immune response. In particular, the disinhibition of the antitumoral T‐cell response by immune checkpoi...
Сохранить в:
| Опубликовано в: : | Cancer Med |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
John Wiley and Sons Inc.
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5943429/ https://ncbi.nlm.nih.gov/pubmed/29658188 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1386 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|